The Clinical Thrombosis Center and Clinical Thrombologist: A New US Health Systems Paradigm for the Management of Venous Thromboembolic Disease
- 1 June 2003
- journal article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 15 (3) , 227-232
- https://doi.org/10.1023/b:thro.0000011378.16223.e4
Abstract
New paradigms for the diagnosis, prophylaxis, acute treatment, and ongoing management of patients with venous thromboembolic disease (VTE), a better understanding of the genotypic and phenotypic mechanisms of thrombophilic states, and the possibility of a greatly expanded armamentarium of antithrombotic therapies are necessitating a more formalized and systematic approach to VTE management. This has required many US healthcare institutions to develop piecemeal approaches in management models for VTE utilizing local champions from a variety of subspecialties. Development of a formalized Clinical Thrombosis Center from an already established Anticoagulant Management Service utilizing a clinical thrombologist, a new role for a physician who has developed expertise in anticoagulation and VTE management, presents a new paradigm in which this disease may be approached at a formalized, institutional level. Thus the clinical thrombologist working through a Clinical Thrombosis Center can develop a system-of-care approach to link the rapid advances in the field of thromboembolism to clinical applications, formulate evidence-based disease management guidelines, and conduct patient-oriented translational clinical research in VTE.Keywords
This publication has 46 references indexed in Scilit:
- A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody SyndromeNew England Journal of Medicine, 2003
- Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with CancerNew England Journal of Medicine, 2003
- Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous ThromboembolismNew England Journal of Medicine, 2003
- Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for CancerNew England Journal of Medicine, 2002
- Outcomes After Withholding Anticoagulation From Patients With Suspected Acute Pulmonary Embolism and Negative Computed Tomographic Findings: A Cohort StudyMayo Clinic Proceedings, 2002
- A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical PatientsNew England Journal of Medicine, 1999
- Low-Molecular-Weight Heparin in the Treatment of Patients with Venous ThromboembolismNew England Journal of Medicine, 1997
- The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous ThromboembolismNew England Journal of Medicine, 1997
- A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at HomeNew England Journal of Medicine, 1996